by Bhavani Srinivasan | Oct 12, 2020
EPHA #A2MDialogues A series of online, live, public dialogues putting the spotlight on actionable solutions for access to medicines for decision-makers in Europe EPHA’s series of online discussions on key access to medicines (A2M) priorities brings together thought...
by European Public Health Alliance | Sep 18, 2020 | Statements
The COVID-19 crisis represents an unprecedented challenge for societies in the European Union as well as at a global level. The European vaccines strategy’s Advance Purchase Agreements (APAs) mechanism has been used by the EU to procure vaccines for COVID-19. We...
by European Public Health Alliance | Sep 18, 2020 | Statements
Our organisations, representing patients, consumers, healthcare professionals and public health interests, very much welcome the INI report on the shortage of medicines voted by the European Parliament on September 17th 2020. We remind that shortages of medicines...
by European Public Health Alliance | Jul 13, 2020 | News Release, Statements
The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health should prevail as leading...
by European Public Health Alliance | Jul 9, 2020 | Opinion
Germany assumed the Presidency of the Council of the European Union from 1 July, but in quite different circumstances from what was originally foreseen, with the response to tackling COVID-19, and its health, economic and social consequences being the defining issue...
